Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Artificial Intelligence and Healthcare
    • Consumer-Driven Health Care
      • Affordable Care Act
      • Cost of Healthcare
      • COVID-19 and Public Health
      • Doctors & Hospitals
      • Public Insurance
      • Policy & Legislation
    • Direct Primary Care
    • Health Economics & Costs
      • Drug Prices & Regulations
      • Health Insurance
      • Health Reform
    • Medical Tourism
    • Telemedicine
    • Medicare
      • Single-Payer/Medicare-for-All
  • Goodman Institute
  • Contact
The Goodman Institute Health Blog

Category: Drug Prices & Regulations

Saturday Links

Posted on June 21, 2025June 21, 2025 by John C. Goodman
  • Britain’s NHS has an elder care problem.
  • Medicare Trustees: The Part A fund will now become insolvent in 2033 — three years earlier than previous predictions. 
  • AEI on the latest Medicare Trustees report.
  • The FDA has granted approval to 270 treatments over its 30 years. Yet they have accounted for well below 1 percent of Medicaid spending.
  • MAHA may bring back whole milk for kids.
  • More reasons why the FDA should require proof of safety, but not efficacy, for new drug approvals.
+

Friday Links

Posted on June 20, 2025June 19, 2025 by John C. Goodman
  • House reconciliation bill creates new subsidies for small business to help employees buy individually owned health insurance.
  • How AEI would reform MA plans.
  • Does exercise really help cancer survival?
  • For diabetes, lifestyle changes are twice as effective as Metformin.
  • Should everyone have a glucose monitor?
+

New Commissioner Faces Uphill Battle to Reform FDA

Posted on June 19, 2025 by Devon Herrick

The Wall Street Journal reports that the new U.S. Food and Drug Administration (FDA) commissioner Marty Makary faces numerous obstacles in his plans to remake the federal agency. Dr. Makary faces a reduction in staff, plummeting staff morale, and internal criticism that he is compromising scientific standards.

+

Thursday Links

Posted on June 19, 2025June 18, 2025 by John C. Goodman
  • “The number of those providing genuine Marcus Welby MD style primary care … continues to fall. And it’s not too hard to figure out why. The average primary doctor makes a whole lot less than their specialty counterparts.”
  • Senate  Finance version of the Big, Beautiful Bill: good, bad and ugly.
  • Do medical licensing laws violate the right to free speech?
  • Paragon Health study: There are 6.4 million ineligible enrollees with (Obamacare) exchange coverage. Note: fraud is easy if the premium is zero.
  • FDA to fast track drug approval if the manufacturer is in line with Trump’s health goals (like producing drugs in this country).
+
  • 1
  • 2
  • 3
  • 4
  • …
  • 188
  • Next

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 36 other subscribers

Popular Topics

©2025 The Goodman Institute Health Blog | Website by Lexicom